Has some membrane stabilizing activity but no intrinsic sympathomimetic activity. Low lipid solubility. Reduces the production of aqueous humor, thus, reducing intraocular pressure. No effect on pupil size or accommodation. Safety and effectiveness have not been determined in children.
Geriatric clients are at greater risk of developing bradycardia.
10 mg once daily either alone or with a diuretic. If the desired effect is not reached, the dose can be increased to 20 mg although doses higher than 20 mg will not increase the therapeutic effect. If used to replace another drug, continue the drug being used and add 1 gtt of betaxolol b.i.d. The previous drug should be discontinued the following day. If transferring from several antiglaucoma drugs being used together, adjust one drug at a time at intervals of not less than 1 week.